CD40-CD40 ligand interactions promote trafficking of CD8+ T cells into the brain and protection against west Nile virus encephalitis

Journal of Virology

Volumn 81, Issue 18, 2007, Pages 9801-9811

  Sitati, Elizabeth ^a   McCandless, Erin E ^a   Klein, Robyn S ^a   Diamond, Michael S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CHEMOKINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; CD40 ANTIGEN; VIRUS ANTIBODY;

ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; BRAIN CELL; CD8+ T LYMPHOCYTE; CELL MIGRATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENCEPHALITIS; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; SPLEEN CELL; STAINING; VIREMIA; WEST NILE FLAVIVIRUS; ANIMAL; ANTIBODY AFFINITY; BLOOD BRAIN BARRIER; BRAIN; CD4+ T LYMPHOCYTE; CELL MOTION; COMPARATIVE STUDY; GENE REARRANGEMENT; GENETICS; HAMSTER; IMMUNOLOGY; MOUSE; MOUSE MUTANT; NERVE CELL; PATHOLOGY; SIGNAL TRANSDUCTION; VIROLOGY; VIRUS INFECTION;

MUS; WEST NILE VIRUS;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; ANTIGENS, CD40; BLOOD-BRAIN BARRIER; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CRICETINAE; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN M; MICE; MICE, KNOCKOUT; NEURONS; SIGNAL TRANSDUCTION; WEST NILE FEVER; WEST NILE VIRUS;

EID: 35348876080     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00941-07     Document Type: Article

References (80)

1. Abromson-Leeman, S., E. Maverakis, R. Bronson, and M. E. Dorf. 2001. CD40-mediated activation of T cells accelerates, but is not required for, encephalitogenic potential of myelin basic protein-recognizing T cells in a model of progressive experimental autoimmune encephalomyelitis. Eur. J. Immunol. 31:527-538.
2. Bachmann, M. F., L. Hunziker, R. M. Zinkernagel, T. Storni, and M. Kopf. 2004. Maintenance of memory CTL responses by T helper cells and CD40-CD40 ligand: antibodies provide the key. Eur. J. Immunol. 34:317-326.
3. Becher, B., B. G. Durell, A. V. Miga, W. F. Hickey, and R. J. Noelle. 2001. The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J. Exp. Med. 193:967-974.
4. Bennett, S. R., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478-480.
5. + CTL response. J. Exp. Med. 183:2129-2142.
6. + cytotoxic T lymphocytes (CTL) but are not required for the maintenance of CTL memory following virus infection. J. Virol. 72:7440-7449.
7. + T-cell memory. Science 297: 2060-2063.
8. Boztug, K., M. J. Carson, N. Pham-Mitchell, V. C. Asensio, J. DeMartino, and I. L. Campbell. 2002. Leukocyte infiltration, but not neurodegeneration, in the CNS of transgenic mice with astrocyte production of the CXC chemokine ligand 10. J. Immunol. 169:1505-1515.
9. Campbell, G. L., A. A. Marfin, R. S. Lanciotti, and D. J. Gubler. 2002. West Nile virus. Lancet Infect. Dis. 2:519-529.
10. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T-cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747-752.
11. Diamond, M. S., B. Shrestha, A. Marri, D. Mahan, and M. Engle. 2003. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J. Virol. 77:2578-2586.
12. Diamond, M. S., E. M. Sitati, L. D. Friend, S. Higgs, B. Shrestha, and M. Engle. 2003. A critical role for induced IgM in the protection against West Nile virus infection. J. Exp. Med. 198:1853-1862.
13. Ebel, G. D., A. P. Dupuis, 2nd, K. Ngo, D. Nicholas, E. Kauffman, S. A. Jones, D. Young, J. Maffei, P. Y. Shi, K. Bernard, and L. D. Kramer. 2001. Partial genetic characterization of West Nile virus strains, New York State, 2000. Emerg. Infect. Dis. 7:650-653.
14. Engelhardt, B., and R. M. Ransohoff. 2005. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol. 26:485-495.
15. Engle, M. J., and M. S. Diamond. 2003. Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice. J. Virol. 77:12941-12949.
16. Eugenin, E. A., K. Osiecki, L. Lopez, H. Goldstein, T. M. Calderon, and J. W. Berman. 2006. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J. Neurosci. 26:1098-1106.
17. Fontana, S., D. Moratto, M. Surinder, M. De Francesco, W. Vermi, S. Ferrari, F. Facchetti, N. Kutukculer, C. Fiorini, M. Duse, P. K. Das, L. D. Notarangelo, A. Plebani, and F. Badolato. 2003. Functional defects of dendritic cells in patients with CD40 deficiency. Blood 102:4099-4106.
18. Franco, M. A., and H. B. Greenberg. 1997. Immunity to rotavirus in T-cell deficient mice. Virology 238:169-179.
19. Glass, W. G., D. H. McDermott, J. K. Lim, S. Lekhong, S. F. Yu, W. A. Frank, J. Pape, R. C. Cheshier, and P. M. Murphy. 2006. CCR5 deficiency increases risk of symptomatic West Nile virus infection. J. Exp. Med. 203:35-40.
20. Granwehr, B. P., K. M. Lillibridge, S. Higgs, P. W. Mason, J. F. Aronson, G. A. Campbell, and A. D. Barrett. 2004. West Nile virus: where are we now? Lancet Infect. Dis. 4:547-556.
21. Grewal, I. S., H. G. Foellmer, K. D. Grewal, J. Xu, F. Hardardottir, J. L. Baron, C. A. Janeway, Jr., and R. A. Flavell. 1996. Requirement for CD40 ligand in costimulation induction, T-cell activation, and experimental allergic encephalomyelitis. Science 273:1864-1867.
22. Grewal, I. S., J. Xu, and R. A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617-620.
23. Harnett, M. M. 2004. CD40: a growing cytoplasmic tale. Sci. STKE 2004: pe25.
24. Hebeis, B. J., K. Klenovsek, P. Rohwer, U. Ritter, A. Schneider, M. Mach, and T. H. Winkler. 2004. Activation of virus-specific memory B cells in the absence of T-cell help. J. Exp. Med. 199:593-602.
25. Hollenbaugh, D., H. D. Ochs, R. J. Noelle, J. A. Ledbetter, and A. Aruffo. 1994. The role of CD40 and its ligand in the regulation of the immune response. Immunol. Rev. 138:23-37.
26. Howard, L. M., A. J. Miga, C. L. Vanderlugt, M. C. Dal Canto, J. D. Laman, R. J. Noelle, and S. D. Miller. 1999. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. J. Clin. Investig. 103:281-290.
27. Jain, A., T. P. Atkinson, P. E. Lipsky, J. E. Slater, D. L. Nelson, and W. Strober. 1999. Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome. J. Clin. Investig. 103:1151-1158.
28. Janeway, C. A., P. Travers, M. Walport, and M. Shlomick. 2001. Immunobiology: the immune system in health and disease, 5th ed. Garland Publishing, New York, NY.
29. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167-178.
30. Ke, Z. J., N. Y. Calingasan, L. A. DeGiorgio, B. T. Volpe, and G. E. Gibson. 2005. CD40-CD40L interactions promote neuronal death in a model of neurodegeneration due to mild impairment of oxidative metabolism. Neurochem. Int. 47:204-215.
31. Ke, Z. J., N. Y. Calingasan, S. S. Karuppagounder, L. A. DeGiorgio, B. T. Volpe, and G. E. Gibson. 2005. CD40L deletion delays neuronal death in a model of neurodegeneration due to mild impairment of oxidative metabolism. J. Neuroimmunol. 164:85-92.
32. + T cells differ for acute and persistent phases of polyomavirus infection. J. Immunol. 176:1814-1824.
33. + T-cell recruitment and control of West Nile virus encephalitis. J. Virol. 79:11457-11466.
34. Lanciotti, R. S., A. J. Kerst, R. S. Nasci, M. S. Godsey, C. J. Mitchell, H. M. Savage, N. Komar, N. A. Panella, B. C. Allen, K. E. Volpe, B. S. Davis, and J. T. Roehrig. 2000. Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J. Clin. Microbiol. 38:4066-4071.
35. Lee, B. O., L. Hartson, and T. D. Randall. 2003. CD40-deficient, influenza-specific CD8 memory T cells develop and function normally in a CD40-sufficient environment. J. Exp. Med. 198:1759-1764.
36. Lee, B. O., J. Rangel-Moreno, J. E. Moyron-Quiroz, L. Hartson, M. Makris, F. Sprague, F. E. Lund, and T. D. Randall. 2005. CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection. J. Immunol. 175:5827-5838.
37. + cytotoxic T lymphocytes. J. Exp. Med. 191:541-550.
38. Mach, F., U. Schonbeck, and P. Libby. 1998. CD40 signaling in vascular cells: a key role in atherosclerosis? Atherosclerosis 137(Suppl.):S89-S95.
39. Maloy, K. J., B. Odermatt, H. Hengartner, and R. M. Zinkernagel. 1998. Interferon gamma-producing γδ T cell-dependent antibody isotype switching in the absence of germinal center formation during virus infection. Proc. Natl. Acad. Sci. USA 95:1160-1165.
40. McCandless, E. E., Q. Wang, B. M. Woerner, J. M. Harper, and R. S. Klein. 2006. CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis. J. Immunol. 177:8053-8064.
41. Mehlhop, E., and M. S. Diamond. 2006. Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J. Exp. Med. 203:1371-1381.
42. Mehlhop, E., K. Whitby, T. Oliphant, A. Marri, M. Engle, and M. S. Diamond. 2005. Complement activation is required for induction of a protective antibody response against West Nile virus infection. J. Virol. 79:7466-7477.
43. Mullbacher, A., M. Lobigs, and E. Lee. 2003. Immunobiology of mosquito-borne encephalitic flaviviruses. Adv. Virus Res. 60:87-120.
44. + T cell accumulation in rheumatoid arthritis synovium. J. Immunol. 165:6590-6598.
45. O'Keefe, G. M., V. T. Nguyen, and E. N. Benveniste. 2002. Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: implications in neurological diseases. J. Neurovirol. 8:496-512.
46. Oliphant, T., M. Engle, G. E. Nybakken, C. Doane, S. Johnson, L. Huang, S. Gorlatov, E. Mehlhop, A. Marri, K. M. Chung, G. D. Ebel, L. D. Kramer, D. H. Fremont, and M. S. Diamond. 2005. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat. Med. 11:522-530.
47. Omari, K. M., R. Chui, and K. Dorovini-Zis. 2004. Induction of beta-chemokine secretion by human brain microvessel endothelial cells via CD40/ CD40L interactions. J. Neuroimmunol. 146:203-208.
48. + T-cell adhesion to endothelium. J. Neuroimmunol. 134:166-178.
49. + T cell functions. J. Exp. Med. 183:2209-2218.
50. + cytotoxic T-cell responses. J. Virol. 75: 11457-11463.
51. Patterson, C. E., J. K. Daley, L. A. Echols, T. E. Lane, and G. F. Rall. 2003. Measles virus infection induces chemokine synthesis by neurons. J. Immunol. 171:3102-3109.
52. Pluvinet, R., J. Petriz, J. Torras, I. Herrero-Fresneda, J. M. Cruzado, J. M. Grinyo, and J. M. Aran. 2004. RNAi-mediated silencing of CD40 prevents leukocyte adhesion on CD154-activated endothelial cells. Blood 104:3642-3646.
53. Ponomarev, E. D., L. P. Shriver, and B. N. Dittel. 2006. CD40 expression by microglial cells is required for their completion of a two-step activation process during central nervous system autoimmune inflammation. J. Immunol. 176:1402-1410.
54. + T-helper and a T-killer cell. Nature 393:474-478.
55. Ryschich, E., A. Marten, E. Schmidt, M. Linnebacher, N. Wentzensen, S. Eisold, E. Klar, M. W. Buchler, and J. Schmidt. 2006. Activating anti-CD40 antibodies induce tumour invasion by cytotoxic T-lymphocytes and inhibition of tumour growth in experimental liver cancer. Eur. J. Cancer 42:981-987.
56. Samuel, M. A., and M. S. Diamond. 2005. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 79:13350-13361.
57. Samuel, M. A., and M. S. Diamond. 2006. Pathogenesis of West Nile virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J. Virol. 80:9349-9360.
58. Schoenberger, S. P., R. E. Toes, E. I. van der Voort, R. Offringa, and C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480-483.
59. Scott, D., and R. K. Gershon. 1970. Determination of total and mercapto-ethanol-resistant antibody in the same serum sample. Clin. Exp. Immunol. 6:313-316.
60. + T cells in control of West Nile virus infection. J. Virol. 78:8312-8321.
61. + T cells require perforin to clear West Nile virus from infected neurons. J. Virol. 80:119-129.
62. Shrestha, B., T. Wang, M. A. Samuel, K. Whitby, J. Craft, E. Fikrig, and M. S. Diamond. 2006. Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J. Virol. 80:5338-5348.
63. + T cell responses are required for clearance of West Nile virus from the central nervous system. J. Virol. 80:12060-12069.
64. Sun, J. C., and M. J. Bevan. 2004. Cutting edge: long-lived CD8 memory and protective immunity in the absence of CD40 expression on CD8 T cells. J. Immunol. 172:3385-3389.
65. Sun, J. C., M. A. Williams, and M. J. Bevan. 2004. CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat. Immunol. 5:927-933.
66. Szomolanyi-Tsuda, E., and R. M. Welsh. 1998. T-cell-independent antiviral antibody responses. Curr. Opin. Immunol. 10:431-435.
67. Tan, J., T. Town, T. Mori, D. Obregon, Y. Wu, A. DelleDonne, A. Rojiani, F. Crawford, R. A. Flavell, and M. Mullan. 2002. CD40 is expressed and functional on neuronal cells. EMBO J. 21:643-652.
68. Tan, J., T. Town, D. Paris, A. Placzek, T. Parker, F. Crawford, H. Yu, J. Humphrey, and M. Mullan. 1999. Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis. J. Neuroimmunol. 97:77-85.
69. Thienel, U., J. Loike, and M. J. Yellin. 1999. CD154 (CD40L) induces human endothelial cell chemokine production and migration of leukocyte subsets. Cell. Immunol. 198:87-95.
70. Ubogu, E. E., M. B. Cossoy, and R. M. Ransohoff. 2006. The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol. Sci. 27:48-55.
71. van Kooten, C., and J. Banchereau. 2000. CD40-CD40 ligand. J. Leukoc. Biol. 67:2-17.
72. Vishnevetsky, D., V. A. Kiyanista, and P. J. Gandhi. 2004. CD40 ligand: a novel target in the fight against cardiovascular disease. Ann. Pharmacother. 38:1500-1508.
73. Wagner, A. H., B. Guldenzoph, B. Lienenluke, and M. Hecker. 2004. CD154/ CD40-mediated expression of CD154 in endothelial cells: consequences for endothelial cell-monocyte interaction. Arterioscler. Thromb. Vasc. Biol. 24: 715-720.
74. Wang, T., E. Scully, Z. Yin, J. H. Kim, S. Wang, J. Yan, M. Mamula, J. F. Anderson, J. Craft, and E. Fikrig. 2003. IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection. J. Immunol. 171:2524-2531.
75. + T cells mediate recovery and immunopathology in West Nile virus encephalitis. J. Virol. 77:13323-13334.
76. Whitmire, J. K., M. K. Slifka, I. S. Grewal, R. A. Flavell, and R. Ahmed. 1996. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection. J. Virol. 70:8375-8381.
77. Wilier, D. O., and S. H. Speck. 2005. Establishment and maintenance of long-term murine gammaherpesvirus 68 latency in B cells in the absence of CD40. J. Virol. 79:2891-2899.
78. Winkelstein, J. A., M. C. Marino, H. Ochs, R. Fuleihan, P. R. Scholl, R. Geha, E. R. Stiehm, and M. E. Conley. 2003. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine 82: 373-384.
79. Yednock, T. A., C. Cannon, L. C. Fritz, F. Sanchez-Madrid, L. Steinman, and N. Karin. 1992. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356:63-66.
80. Yellin, M. J., J. Brett, D. Baum, A. Matsushima, M. Szabolcs, D. Stern, and L. Chess. 1995. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J. Exp. Med. 182:1857-1864.